|
|
Volumn 25, Issue 12, 2008, Pages 989-992
|
|
Treatment-resistant depression: recent developments and future directions.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 METHYLTETRAHYDROFOLIC ACID;
5-METHYLTETRAHYDROFOLATE;
ANTIDEPRESSANT AGENT;
ARIPIPRAZOLE;
NEUROLEPTIC AGENT;
PIPERAZINE DERIVATIVE;
QUINOLONE DERIVATIVE;
TETRAHYDROFOLIC ACID DERIVATIVE;
UNCLASSIFIED DRUG;
BRAIN DEPTH STIMULATION;
CLASSIFICATION;
CLINICAL TRIAL;
DRUG RESISTANCE;
ELECTROCONVULSIVE THERAPY;
HUMAN;
MAJOR DEPRESSION;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
PSYCHOLOGICAL ASPECT;
REVIEW;
TRANSCRANIAL MAGNETIC STIMULATION;
TREATMENT OUTCOME;
VAGUS NERVE STIMULATION;
ANTIDEPRESSIVE AGENTS;
ANTIPSYCHOTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
COMBINED MODALITY THERAPY;
DEEP BRAIN STIMULATION;
DEPRESSIVE DISORDER, MAJOR;
DRUG RESISTANCE;
ELECTROCONVULSIVE THERAPY;
HUMANS;
PIPERAZINES;
PROGNOSIS;
QUINOLONES;
TETRAHYDROFOLATES;
TRANSCRANIAL MAGNETIC STIMULATION;
TREATMENT OUTCOME;
VAGUS NERVE STIMULATION;
|
|
EID: 61849083107
PISSN: None
EISSN: 15206394
Source Type: Journal
DOI: 10.1002/da.20540 Document Type: Review |
|
Times cited : (41)
|
|
References (20)
|
